Drug intelligence / Profile preview

calotropis gigantea root extract

Development stage
Preclinical
Modality
Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
Administration
Oral, Topical
01

Overview

Calotropis gigantea root extract is a botanical preparation derived from the roots of the Calotropis gigantea plant, a traditional medicinal herb widely used in Ayurveda and other folk medicine systems. The extract contains a variety of bioactive compounds including cardiac glycosides (such as calotropin, calactin, uscharin), triterpenoids (β-amyrin, giganteol), flavonoids, saponins, alkaloids (including mudarine), and oxypregnane-oligoglycosides[6][10]. Traditionally and experimentally, it has been used for its anti-inflammatory, analgesic (pain-relieving), antipyretic (fever-reducing), wound healing, anti-bacterial/anti-microbial, cytotoxic/anticancer (notably against certain cancer cell lines in vitro), anticonvulsant/CNS effects (e.g., for epilepsy), antidiabetic activity and as an abortifacient[2][3][4][5][7]. It is also reported to have antioxidant properties due to its phenolic content[2]. In traditional medicine systems such as Ayurveda and Unani medicine in India and Southeast Asia/Africa it has been used to treat leprosy, eczema, syphilis, elephantiasis, ulceration/wounds/boils/skin infections/ulcers/inflammation/joint pain/muscle pain/asthma/coughs/digestive disorders including diarrhea/dysentery/cramps/nausea/vomiting/gout/high fever/scorpion/snake bites[1][2][3][5]. The mechanism of action is believed to be multi-targeted due to the diverse phytochemical profile; notable actions include inhibition of inflammatory mediators via suppression of cyclooxygenase/lipoxygenase pathways by triterpenoids/flavonoids; cytotoxicity via cardiac glycoside-induced apoptosis; antimicrobial effects through membrane disruption or enzyme inhibition; CNS depressant activity possibly via GABAergic modulation or ion channel effects. However clinical evidence remains limited beyond preclinical studies. Use during pregnancy/lactation is contraindicated due to uterotonic/emmenagogue properties.

Other names
Calotropis gigantea rootCalotropis root extractArka root extract
02

Targets

15-LOX (Lysyl Oxidase)COXLPS (Lipopolysaccharide)

Beyond the preview

Go deeper on calotropis gigantea root extract.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on calotropis gigantea root extract.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call